Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: The EVEREST clinical status trials

The Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators

Research output: Contribution to journal › Article › peer-review

645 Scopus citations

Fingerprint

Dive into the research topics of 'Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: The EVEREST clinical status trials'. Together they form a unique fingerprint.

Medicine & Life Sciences